David S. Soane,Robert P. Mahoney,Philip Wuthrich,Daniel G. Greene
申请号：
US16789628
公开号：
US20200282065A1
申请日:
2020.02.13
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention encompasses therapeutic formulations comprising a protein active ingredient and a stabilizing excipient, methods of improving stability in a therapeutic formulation comprising a protein active ingredient by adding a stability-improving amount of a stabilizing excipient to the therapeutic formulation, and methods of reducing adverse infusion-related effects in a patient, comprising administering to a patient in need thereof a therapeutic formulation comprising a protein active ingredient and a stabilizing excipient.
